WHO Recognizes GLP-1 Weight-Loss and Diabetes Drugs as Essential Medicines
TL;DR
The WHO has added new drugs for obesity and diabetes, including GLP-1 medications like Ozempic and Mounjaro, to its essential medicines list, emphasizing the need for affordable generics in developing countries and highlighting their proven clinical benefits and potential for global health impact.
- WHO adds weight-loss, diabetes drugs to essential medicines list Al Jazeera
- WHO adds GLP-1 drugs for diabetes, others to essential medicines list Reuters
- WHO updates list of essential medicines to include key cancer, diabetes treatments World Health Organization (WHO)
- WHO Adds Ozempic and Mounjaro to Its List of Essential Medicines Bloomberg.com
- WHO adds GLP-1 weight loss drugs to list of the world's essential medicines for the first time Quartz
Want the full story? Read the original reporting
Read on Al Jazeera